Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
195.34
-1.11 (-0.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
880,438
Open
196.45
Bid (Size)
194.10 (100)
Ask (Size)
199.90 (200)
Prev. Close
196.45
Today's Range
195.14 - 200.66
52wk Range
121.05 - 205.97
Shares Outstanding
146,800,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Revolution Medicines Is Up 97% This Year: Here Are the Bull and Bear Cases for This Soaring Biotech Stock.
↗
June 05, 2026
Can the drugmaker justify its valuation?
Via
The Motley Fool
BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm
June 04, 2026
From
The Schall Law Firm
Via
Business Wire
Performance
YTD
+9.9%
+9.9%
1 Month
+2.4%
+2.4%
3 Month
+5.7%
+5.7%
6 Month
+7.7%
+7.7%
1 Year
+49.8%
+49.8%
More News
Read More
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
June 04, 2026
From
Biogen Inc.
Via
GlobeNewswire
Unusual volume S&P500 stocks in Thursday's session
↗
May 14, 2026
Via
Chartmill
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
June 04, 2026
From
Biogen Inc.
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
June 02, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
May 26, 2026
From
Pomerantz LLP
Via
GlobeNewswire
MarketBeat Week in Review – 05/18 - 05/22
↗
May 23, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
↗
May 22, 2026
Via
MarketBeat
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
May 21, 2026
From
Denali Therapeutics Inc.
Via
GlobeNewswire
BIIB Investor Alert: Levi & Korsinsky Investigates Biogen Inc. (BIIB) for Potential Securities Fraud
May 19, 2026
From
Levi & Korsinsky, LLP
Via
Business Wire
Biogen Conference: Lupus, Kidney Programs Take Center Stage in Immunology Push
↗
May 14, 2026
Via
MarketBeat
Stay informed with the top movers within the S&P500 index on Thursday.
↗
May 14, 2026
Via
Chartmill
Best Healthcare Stocks to Buy in 2026
↗
May 14, 2026
Via
The Motley Fool
Thursday's session: top gainers and losers in the S&P500 index
↗
May 14, 2026
Via
Chartmill
These S&P500 stocks are gapping in today's session
↗
May 14, 2026
Via
Chartmill
Discover the top S&P500 movers in Thursday's pre-market session.
↗
May 14, 2026
Via
Chartmill
Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease
May 14, 2026
From
Biogen Inc.
Via
GlobeNewswire
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
May 11, 2026
Via
Investor Brand Network
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Targets CNS Drug Delivery Opportunity as Brain Therapeutics Innovation Accelerates
May 11, 2026
Via
Investor Brand Network
Topics
Intellectual Property
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
May 11, 2026
From
BioMedWire
Via
GlobeNewswire
3 Healthcare Stocks We’re Skeptical Of
May 11, 2026
Via
StockStory
3 Value Stocks We Approach with Caution
May 08, 2026
Via
StockStory
Biogen Analysts Boost Their Forecasts Following Upbeat Q1 Earnings
↗
April 30, 2026
Via
Benzinga
Why Biogen Stock Was a Winner on Wednesday
↗
April 29, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Biogen Idec publicly traded?
Yes, Biogen Idec is publicly traded.
What exchange does Biogen Idec trade on?
Biogen Idec trades on the Nasdaq Stock Market
What is the ticker symbol for Biogen Idec?
The ticker symbol for Biogen Idec is BIIB on the Nasdaq Stock Market
What is the current price of Biogen Idec?
The current price of Biogen Idec is 195.34
When was Biogen Idec last traded?
The last trade of Biogen Idec was at 06/05/26 04:00 PM ET
What is the market capitalization of Biogen Idec?
The market capitalization of Biogen Idec is 28.68B
How many shares of Biogen Idec are outstanding?
Biogen Idec has 29B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.